Legal & General Group Plc Increases Holdings in Chemed Corp. (CHE)
Legal & General Group Plc grew its position in shares of Chemed Corp. (NYSE:CHE) by 9.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,177 shares of the company’s stock after purchasing an additional 2,709 shares during the quarter. Legal & General Group Plc owned approximately 0.19% of Chemed Corp. worth $6,378,000 as of its most recent SEC filing.
Several other large investors have also recently bought and sold shares of CHE. BlackRock Inc. increased its holdings in shares of Chemed Corp. by 145,760.9% during the 1st quarter. BlackRock Inc. now owns 1,955,994 shares of the company’s stock valued at $357,341,000 after purchasing an additional 1,954,653 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Chemed Corp. by 7.5% during the 1st quarter. Vanguard Group Inc. now owns 1,795,773 shares of the company’s stock valued at $328,070,000 after purchasing an additional 125,018 shares in the last quarter. State Street Corp increased its holdings in shares of Chemed Corp. by 9.1% during the 1st quarter. State Street Corp now owns 445,367 shares of the company’s stock valued at $81,370,000 after purchasing an additional 37,085 shares in the last quarter. Oppenheimer Asset Management Inc. purchased a new position in shares of Chemed Corp. during the 1st quarter valued at approximately $4,445,000. Finally, Neuberger Berman Group LLC increased its holdings in shares of Chemed Corp. by 2.2% during the 1st quarter. Neuberger Berman Group LLC now owns 1,060,403 shares of the company’s stock valued at $193,725,000 after purchasing an additional 23,306 shares in the last quarter. 96.96% of the stock is owned by hedge funds and other institutional investors.
CHE has been the subject of several recent research reports. TheStreet lowered shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $209.00 target price on shares of Chemed Corp. in a report on Friday, September 1st. KeyCorp initiated coverage on shares of Chemed Corp. in a report on Monday, August 28th. They set a “sector weight” rating for the company. Zacks Investment Research lowered shares of Chemed Corp. from a “buy” rating to a “hold” rating in a report on Tuesday, August 22nd. Finally, Oppenheimer Holdings, Inc. lifted their target price on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Thursday, July 27th. Three analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Chemed Corp. presently has an average rating of “Hold” and an average target price of $214.00.
Chemed Corp. (NYSE:CHE) opened at 196.66 on Thursday. The stock’s 50 day moving average is $195.58 and its 200 day moving average is $195.20. The stock has a market capitalization of $3.14 billion, a price-to-earnings ratio of 48.79 and a beta of 1.14. Chemed Corp. has a 12-month low of $132.92 and a 12-month high of $216.01.
Chemed Corp. (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 25th. The company reported $2.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.89 by $0.26. The firm had revenue of $415.06 million during the quarter, compared to analysts’ expectations of $407.56 million. Chemed Corp. had a return on equity of 26.18% and a net margin of 4.16%. Chemed Corp.’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.80 earnings per share. Equities research analysts forecast that Chemed Corp. will post $8.21 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 1st. Shareholders of record on Monday, August 14th were given a $0.28 dividend. This is a boost from Chemed Corp.’s previous quarterly dividend of $0.26. The ex-dividend date of this dividend was Thursday, August 10th. This represents a $1.12 annualized dividend and a yield of 0.57%. Chemed Corp.’s dividend payout ratio is presently 28.07%.
In other Chemed Corp. news, Director George J. Walsh III acquired 1,000 shares of the business’s stock in a transaction on Monday, June 26th. The stock was purchased at an average price of $204.56 per share, for a total transaction of $204,560.00. Following the completion of the transaction, the director now owns 7,908 shares of the company’s stock, valued at approximately $1,617,660.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Kevin J. Mcnamara sold 15,000 shares of the stock in a transaction on Friday, July 28th. The stock was sold at an average price of $201.16, for a total value of $3,017,400.00. Following the completion of the transaction, the insider now owns 173,801 shares of the company’s stock, valued at approximately $34,961,809.16. The disclosure for this sale can be found here. Corporate insiders own 5.32% of the company’s stock.
About Chemed Corp.
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Stock Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related stocks with our FREE daily email newsletter.